Hangzhou Tigermed Consulting Statistics

Total Valuation

Hangzhou Tigermed Consulting has a market cap or net worth of CNY 48.68 billion. The enterprise value is 54.14 billion.

Market Cap	48.68B
Enterprise Value	54.14B

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	Jul 12, 2024

Share Statistics

Hangzhou Tigermed Consulting has 861.29 million shares outstanding. The number of shares has decreased by -0.44% in one year.

Current Share Class	n/a
Shares Outstanding	861.29M
Shares Change (YoY)	-0.44%
Shares Change (QoQ)	+0.94%
Owned by Insiders (%)	27.76%
Owned by Institutions (%)	34.46%
Float	622.16M

Valuation Ratios

The trailing PE ratio is 54.96 and the forward PE ratio is 31.54. Hangzhou Tigermed Consulting's PEG ratio is 4.11.

PE Ratio	54.96
Forward PE	31.54
PS Ratio	7.74
PB Ratio	2.51
P/TBV Ratio	2.72
P/FCF Ratio	77.40
P/OCF Ratio	n/a
PEG Ratio	4.11

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.53, with an EV/FCF ratio of 79.89.

EV / Earnings	56.48
EV / Sales	7.96
EV / EBITDA	32.53
EV / EBIT	40.44
EV / FCF	79.89

Financial Position

The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.17.

Current Ratio	1.37
Quick Ratio	1.32
Debt / Equity	0.17
Debt / EBITDA	2.49
Debt / FCF	6.13
Interest Coverage	8.85

Financial Efficiency

Return on equity (ROE) is 4.19% and return on invested capital (ROIC) is 2.96%.

Return on Equity (ROE)	4.19%
Return on Assets (ROA)	2.77%
Return on Capital (ROIC)	2.96%
Revenue Per Employee	701,080
Profits Per Employee	98,822
Employee Count	9,701
Asset Turnover	0.23
Inventory Turnover	172.55

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.94% in the last 52 weeks. The beta is 0.84, so Hangzhou Tigermed Consulting's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	+15.94%
50-Day Moving Average	64.50
200-Day Moving Average	55.57
Relative Strength Index (RSI)	41.93
Average Volume (20 Days)	8,085,756

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hangzhou Tigermed Consulting had revenue of CNY 6.80 billion and earned 958.67 million in profits. Earnings per share was 1.11.

Revenue	6.80B
Gross Profit	2.54B
Operating Income	1.34B
Pretax Income	1.26B
Net Income	958.67M
EBITDA	1.54B
EBIT	1.34B
Earnings Per Share (EPS)	1.11

Full Income Statement

Balance Sheet

The company has 2.04 billion in cash and 4.15 billion in debt, giving a net cash position of -2.11 billion or -2.45 per share.

Cash & Cash Equivalents	2.04B
Total Debt	4.15B
Net Cash	-2.11B
Net Cash Per Share	-2.45
Equity (Book Value)	24.42B
Book Value Per Share	24.30
Working Capital	1.75B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.06 billion and capital expenditures -378.86 million, giving a free cash flow of 677.70 million.

Operating Cash Flow	1.06B
Capital Expenditures	-378.86M
Free Cash Flow	677.70M
FCF Per Share	0.79

Full Cash Flow Statement

Margins

Gross margin is 37.29%, with operating and profit margins of 19.69% and 14.10%.

Gross Margin	37.29%
Operating Margin	19.69%
Pretax Margin	18.54%
Profit Margin	14.10%
EBITDA Margin	22.70%
EBIT Margin	19.69%
FCF Margin	9.96%

Dividends & Yields

This stock pays an annual dividend of 0.57, which amounts to a dividend yield of 0.93%.

Dividend Per Share	0.57
Dividend Yield	0.93%
Dividend Growth (YoY)	3.27%
Years of Dividend Growth	3
Payout Ratio	65.49%
Buyback Yield	0.44%
Shareholder Yield	1.37%
Earnings Yield	1.82%
FCF Yield	1.29%

Dividend Details

Stock Splits

The last stock split was on July 1, 2019. It was a forward split with a ratio of 1.5.

Last Split Date	Jul 1, 2019
Split Type	Forward
Split Ratio	1.5

Scores

Hangzhou Tigermed Consulting has an Altman Z-Score of 5.35.

Altman Z-Score	5.35
Piotroski F-Score	n/a